Evidence map›Paper›PMID 30863369›Full record

ArticleFrontiers in microbiology2019

Nasal Resistome Development in Infants With Cystic Fibrosis in the First Year of Life.

Aurélie Allemann, Julia G Kraemer, Insa Korten, Kathryn Ramsey, Carmen Casaulta, SCILD Study Group, Daniel Wüthrich, Alban Ramette, Andrea Endimiani, Philipp Latzin and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Observational
  3. Resistome in the indoor dust samples from workplaces and households: a pilot study.Frontiers in cellular and infection microbiology · 2024
    Article
  4. Article
  5. Antibiotic resistance in chronic respiratory diseases: from susceptibility testing to the resistome.European respiratory review : an official journal of the European Respiratory Society · 2022
    Review
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Aurélie AllemannInstitute for Infectious Diseases, University of Bern, Bern, Switzerland.
Julia G KraemerInstitute for Infectious Diseases, University of Bern, Bern, Switzerland.
Insa KortenGraduate School for Cellular and Biomedical Sciences, University of Bern, Bern, Switzerland.
Kathryn RamseyDivision of Respiratory Medicine, Department of Paediatrics, Inselspital, University of Bern, Bern, Switzerland.
Carmen CasaultaDivision of Respiratory Medicine, Department of Paediatrics, Inselspital, University of Bern, Bern, Switzerland.
SCILD Study Group
Daniel WüthrichApplied Microbiology Research Unit, Department of Biomedicine, University of Basel, Basel, Switzerland.
Alban RametteInstitute for Infectious Diseases, University of Bern, Bern, Switzerland.
Andrea EndimianiInstitute for Infectious Diseases, University of Bern, Bern, Switzerland.
Philipp LatzinDivision of Respiratory Medicine, Department of Paediatrics, Inselspital, University of Bern, Bern, Switzerland.
Markus HiltyInstitute for Infectious Diseases, University of Bern, Bern, Switzerland.
University of Bern · CHUniversity of Basel · CHUniversity of Geneva · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Polymicrobial infections of the respiratory tract due to antibiotic resistant bacteria are a great concern in patients with cystic fibrosis (CF). We therefore aimed at establishing a functional metagenomic method to analyze the nasal resistome in infants with CF within the first year of life. We included samples from patients before antibiotic treatment, which allowed obtaining information regarding natural status of the resistome. In total, we analyzed 130 nasal swabs from 26 infants with CF and screened for β-lactams (ampicillin, amoxicillin-clavulanic acid, and cefuroxime) and other classes of antibiotic resistances (tetracycline, chloramphenicol and trimethoprim-sulfamethoxazole). For 69 swabs (53% of total), we found at least one non-susceptible phenotype. Analyses of the inserts recovered from non-susceptible clones by nanopore MinION sequencing revealed a large reservoir of resistance genes including mobile elements within the antibiotic naïve samples. Comparing the data of the resistome with the microbiota composition showed that the bacterial phyla and operational taxonomic units (OTUs) of the microbiota rather than the antibiotic treatment were associated with the majority of non-susceptible phenotypes in the resistome. Future studies will reveal if characterization of the resistome can help in clinical decision-making in patients with CF.

Indexed as

antibioticsbeta-lactamasesfunctional metagenomicsnasal swabsresistance

Identifiers

PMID30863369
PMCPMC6399209
OpenAlexW2918110853

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.